Three years after litigation started over technology used in an mRNA vaccine for COVID-19, Biontech SE is acquiring its ...

Wandercraft SAS secured $75 million in funding in a series D round to grow its AI-powered robotics solutions. Funds will be ...

Researchers at the Buck Institute for Research on Aging have developed an epigenetic clock that could predict an individual’s intrinsic capacity score, a composite score that is a measure of healthy ...

The U.K.’s National Health Service reported June 10 that patients in the U.K. will be the first in Europe to enjoy the ...

South Korea’s Ministry of Food and Drug Safety on June 9 approved Vuno Inc’s AI-based Med-DeepECG Kidney software as a ...

Mosanna Therapeutics secured $80 million in a series A round to develop MOS-118 as a treatment for the nearly 1 billion ...

Deepcure Inc. has nominated DC-15442, an oral selective STAT6 inhibitor, as its second development candidate. DC-15442 is ...

Loss-of-function variants in the ELP1 gene are the most prevalent predisposing genetic factors in childhood medulloblastoma, ...

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk ...

When it comes to the U.S. biopharma market, pricing seems to be the driving focus of most congressional conversations – and ...

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate ...

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...